Note: Ingredients listed on restricted chemical lists
EC/CAS
7681-57-4
Name of the chemical
Sodium metabisulfite
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Version
5.0
Revision date
2025-08-14
Product name
Diprivan
Chemical name
(Active
1.2.1 Relevant identified uses
Pharmaceutical
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals
GHS Information
Signal word
Not available
Section 2
SECTION 2: Hazards identification
Health hazards
2 Fire Hazard: 1 Reactivity: 1 In the workplace may be harmful if swallowed. Known adverse effects by other routes are not known. In therapeutic use, this product may produce irregular heartbeat, reduced blood pressure, convulsions, swelling and sleepiness. Therapeutic use has been associated with both fatal and life-threatening anaphylactic and anaphylactoid reactions. It is not known if these effects are possible as a result of workplace exposure. Flammability Hazards: This product is expected to be combustible. If heated to high temperatures for a prolonged period, the material may ignite. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds, including carbon and nitrogen oxides. Reactivity Hazards: This product is not reactive.
Signal word
Not available
Hazard statements
Symbol(s), and/or
Precautionary statements
Description of Hazards
Environmental hazards
Release of large quantity may cause harm to animals and aquatic organisms if accidentally released to the environment. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding. (d) Unknown Acute Toxicity: Not available